Last reviewed · How we verify
NCT05735561: PHF-D
Proximal Humerus Fracture Dislocation Direction and Avascular Necrosis
trial testing X-Ray in Proximal Humeral Fracture in 25 participants. Completed in 31 August 2023.
31 July 2023
Quick facts
| Lead sponsor | Fraser Orthopaedic Research Society |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 25 |
| Start date | 15 February 2023 |
| Primary completion | 31 July 2023 |
| Estimated completion | 31 August 2023 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- X-Ray
Conditions studied
- Proximal Humeral Fracture — all drugs for Proximal Humeral Fracture →
- Dislocation — all drugs for Dislocation →
- Dislocation Shoulder — all drugs for Dislocation Shoulder →
- Avascular Necrosis — all drugs for Avascular Necrosis →
Sponsor
Fraser Orthopaedic Research Society
Who can join
18 and older, any sex, with Proximal Humeral Fracture or Dislocation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to see if there is a connection between a proximal humerus fracture dislocation direction and the likelihood of developing avascular necrosis. Utilizing a retrospective cohort from the last ten years we hope to bring consenting patients back for a single visit to have x-rays and complete patient reported outcome measures to assess for evidence of avascular necrosis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05735561
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of X-Ray
Trials testing the same drug.
- NCT04820491 — Efficient Anterior Shoulder Ultrasound Reduction Multicenter Prospective Randomized Trial · NA · terminated
- NCT04651543 — X-Ray Follow-up in Proximal Humeral Fractures Conservatively Treated · unknown
- NCT02981888 — Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome · completed
Other recruiting trials for Proximal Humeral Fracture
Currently open trials in the same condition.
- NCT06416618 — Surgical Versus Non-surgical Treatment of Displaced Proximal Humerus Fracture in Adults Aged 50 to 65 Years · NA · recruiting
- NCT05703958 — Exactech Proximal Humerus Fracture Plate System Post Market Clinical Follow-up · recruiting
- NCT06444828 — Comparing Outcomes of Non-surgical Versus Surgical Treatment of Shoulder Fractures With Different Shoulder Replacements · NA · active not recruiting
- NCT06133920 — Duration of Immobilization After Reverse Total Arthroplasty for Proximal Humerus Fractures · recruiting
- NCT04523415 — Researches About Proximal Humerus Fractures · recruiting
Other Fraser Orthopaedic Research Society trials
Trials by the same sponsor.
- NCT06605482 — Early Fixation for Diaphyseal Humeral Shaft Fractures in the Elderly Patients · recruiting
- NCT05135949 — Strength After Elbow Fractures in the Elderly · recruiting
- NCT03032653 — Immediate Weight-Bearing Ankle Study · NA · completed
- NCT02750072 — INfrapatellar Versus SUprapatellar Reamed Intramedullary Nailing for Fractures of the Tibia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05735561 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fraser Orthopaedic Research Society
- Last refreshed: 13 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05735561.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing